Triple-digit revenue growth and a bar-raising deal with pop star PepsiCo can do wonders for a stock's effervescence. With Celsius' unique proposition -- a line of flavored canned beverages that claim to help active drinkers burn calories by improving near-term metabolism rates -- this could be a financial workout that works out. Celsius has been pulling back its distribution overseas, and international sales shrank from 20% in the first half of last year to just 6% of the revenue mix this time around.
How the FDA's thinking and Outset Medical's are aligned. Plus, Motley Fool producer Ricky Mulvey talks with Motley Fool senior analyst Asit Sharma about becoming less distracted as an investor, and an insurance company with a very clear focus.
Here is how Campbell Soup (CPB) and PepsiCo (PEP) have performed compared to their sector so far this year.